HORSHAM, Pa. -- The Drug Information Association (DIA), a nonprofit association that provides a neutral forum for information exchange for drug discovery and lifecycle management processes, has opened an office in Beijing, China.

Dr. Ling Su, DIA Board Member and VP of Clinical R&D - Asia Pacific, Wyeth, China, will lead the advisory council in China.

"China's pharmaceutical industry has become a major force in drug discovery and development," said William Brassington, Acting DIA Worldwide Executive Director. "As the premier provider of neutral global forums for the exchange of information, education, and training, it is imperative that we solidify our presence in the region."

The Provisional Advisory Council of China (pACC) was established in May 2008, and will continue to provide support and strategic oversight for DIA's presence in China. The pACC will focus on developing a strong membership and volunteer base, strategic alliances, conferences and training programs, and local and student chapters.

"An influx of western-trained scientists and increased access to global markets are extending the development opportunities available in China," says Dr. Su. "DIA's presence in China will certainly contribute to meeting the enormous needs in training, education, and information sharing and exchange in global drug development and access to new medicines."